The application of deep learning in cancer research, particularly in early diagnosis, case understanding, and treatment strategy design, emphasizes the need for high-quality data. Generative AI, especially Generative Adversarial Networks (GANs), has emerged as a leading solution to challenges like class imbalance, robust learning, and model training, while addressing issues stemming from patient privacy and the scarcity of real data. Despite their promise, GANs face several challenges, both inherent and specific to histopathology data. Inherent issues include training imbalance, mode collapse, linear learning from insufficient discriminator feedback, and hard boundary convergence due to stringent feedback. Histopathology data presents a unique challenge with its complex representation, high spatial resolution, and multiscale features. To address these challenges, we propose a framework consisting of two components. First, we introduce a contrastive learning-based Multistage Progressive Finetuning Siamese Neural Network (MFT-SNN) for assessing the similarity between histopathology patches. Second, we implement a Reinforcement Learning-based External Optimizer (RL-EO) within the GAN training loop, serving as a reward signal generator. The modified discriminator loss function incorporates a weighted reward, guiding the GAN to maximize this reward while minimizing loss. This approach offers an external optimization guide to the discriminator, preventing generator overfitting and ensuring smooth convergence. Our proposed solution has been benchmarked against state-of-the-art (SOTA) GANs and a Denoising Diffusion Probabilistic model, outperforming previous SOTA across various metrics, including FID score, KID score, Perceptual Path Length, and downstream classification tasks.